View in EDS HTML Full Text PDF Full Text

Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation, fibrosis and oxidative stress.

Saved in:

Bibliographic Details
Title:	Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation, fibrosis and oxidative stress.
Authors:	Jiang, Xinghao¹ (AUTHOR), Wu, Qing¹ (AUTHOR), Opoku, Yeboah Kwaku^1,2 (AUTHOR), Zou, Yimeng¹ (AUTHOR), Wang, Dan¹ (AUTHOR), Hu, Changhui¹ (AUTHOR), Ren, Guiping^1,3 (AUTHOR) renguiping@126.com
Source:	Basic & Clinical Pharmacology & Toxicology. Dec2022, Vol. 131 Issue 6, p474-486. 13p.
Database:	Environment Complete
Full text is not displayed to guests. Login for full access.

Description
ISSN:	17427835
DOI:	10.1111/bcpt.13793